Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression

Journal of Ethnopharmacology

Volumn 141, Issue 1, 2012, Pages 257-264

  Liu, Jingshu ^a   Qiao, Wei ^a   Yang, Yi ^a   Ren, Liyan ^a   Sun, Yan ^a   Wang, Shaoxun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Antidepressant; Behavior; Chinese herbal medicine; Monoamine neurotransmitters; Monoamine oxidase; Suanzaorenhehuan Formula

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIDEPRESSANT AGENT; FLUOXETINE; HERBACEOUS AGENT; NEUROTRANSMITTER; NORADRENALIN; SUANZAORENHEHUAN EXTRACT; UNCLASSIFIED DRUG; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ENZYME ACTIVITY; FRONTAL CORTEX; HEAD TWITCH; HERBAL MEDICINE; HIPPOCAMPUS; IMMOBILIZATION; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN BLOOD LEVEL; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; TREATMENT DURATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CHEMICAL FRACTIONATION; CYCLOHEXANOLS; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ETHANOL; HIPPOCAMPUS; MALE; MICE; MICE, INBRED ICR; MONOAMINE OXIDASE; MOTOR ACTIVITY; NOREPINEPHRINE; PHYTOTHERAPY; PLANTS, MEDICINAL; PREFRONTAL CORTEX; SEROTONIN; SOLVENTS; TIME FACTORS;

MUS;

EID: 84862830223     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.02.026     Document Type: Article

References (48)

1. L. An, Y.Z. Zhang, N.J. Yu, X.M. Liu, N. Zhao, L. Yuan, and Y.F. Li Role for serotonin in the antidepressant-like effect of a flavonoid extract of Xiaobuxin-Tang Pharmacology Biochemistry and Behavior 89 2008 572 580
2. J. Archer Tests for emotionality in rats and mice: a review Animal Behaviour 21 1973 205 235
3. F. Bai, X. Li, M. Clay, T. Lindstrom, and P. Skolnick Intra and interstrain differences in models of "behavioral despair" Pharmacology Biochemistry and Behavior 70 2001 187 192
4. M.K. Bhutani, M. Bishnoi, and S.K. Kulkarni Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes Pharmacology Biochemistry and Behavior 92 2009 39 43
5. F. Borsini, and A. Meli Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94 1988 147 160
6. M. Bourin, A.J. Fiocco, and F. Clenet How valuable are animal models in defining antidepressant activity? Human Psychopharmacology 16 2001 9 21
7. N. Brunello, P. Blier, L.L. Judd, J. Mendlewicz, C.J. Nelson, D. Souery, J. Zohar, and G. Racagni Noradrenaline in mood and anxiety disorders: basic and clinical studies International Clinical Psychopharmacology 18 2003 191 202
8. V. Butterweck, T. Bockers, B. Korte, W. Wittkowski, and H. Winterhoff Long-term effects of St John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus Brain Research 930 2002 21 29
9. A. Coppen The biochemistry of affective disorders British Journal of Psychiatry 113 1967 1237 1264
10. S.J. Corne, R.W. Pickering, and B.T. Warner A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine British Journal of Pharmacology and Chemotherapy 20 1963 106 120
11. J.F. Cryan, R.J. Valentino, and I. Lucki Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test Neuroscience & Biobehavioral Reviews 29 2005 547 569
12. K.F. Croom, C.M. Perry, and G.L. Plosker Mirtazapine: a review of its use in major depression and other psychiatric disorders CNS Drugs 23 2009 427 452
13. M.P. Cunha, D.G. Machado, L.E.B. Bettio, J.C. Capra, and A.L.S. Rodrigues Interaction of zinc with antidepressants in the tail suspension test Progress in Neuro-psychopharmacology and Biological Psychiatry 32 2008 1913 1920
14. G. Curzon, and A.R. Green Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain British Journal of Pharmacology 39 1970 653 655
15. P.S. D'Aquila, M. Collu, G.L. Gessa, and G. Serra The role of dopamine in the mechanism of action of antidepressant drugs European Journal of Pharmacology 405 2000 365 373
16. P. Delgado, and F. Moreno Antidepressants and the brain International Clinical Psychopharmacology 14 1999 9 16
17. P. Deniker The search for new antidepressants and related drugs K.F. Tipton, D. Dostert, M.S. Benedtti, Monoamine Oxidase and Diseases, Prospects for Therapy with Reversible Inhibitors 1984 Academic Press New York 3 8
18. W.C. Drevets Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders Current Opinion in Neurobiology 11 2001 240 249
19. C. Ducottet, G. Griebel, and C. Belzung Effects of the selective nonpeptide corticotrophin-releasing factor 1 antagonist antalarmin in the chronic mild stress model of depression in mice Progress in Neuro- psychopharmacology and Biological Psychiatry 27 2003 625 631
20. R.S. Duman, G.R. Heninger, and E.J. Nestler A molecular and cellar theory of depression Archives of General Psychiatry 54 1997 597 606
21. A.S. Elhwuegi Central monoamines and their role in major depression Progress in Neuro-psychopharmacology and Biological Psychiatry 28 2004 435 451
22. F.G. Graeff, F.S. Guimarães, T.G. De Andrade, and J.F. Deakin Role of 5-HT in stress, anxiety and depression Pharmacology Biochemistry and Behavior 54 1996 129 141
23. H. Han, Y. Ma, J.S. Eun, R.H. Li, J.T. Hong, M.K. Lee, and K.W. Oh Anxiolytic-like effects of sanjoinine A isolated from Zizyphi Spinosi Semen: possible involvement of GABAergic transmission Pharmacology Biochemistry and Behavior 92 2009 206 213
24. S. Kapur, and J.J. Mann Role of the dopaminergic system in depression Biological Psychiatry 32 1992 1 17
25. R.C. Kessler, J. Soukup, R.B. Davis, D.F. Foster, S.A. Wilkey, M.I. Van Rompay, and D.M. Eisenberg The use of complementary and alternative therapies to treat anxiety and depression in the United States American Journal of Psychiatry 158 2001 289 294
26. L. Li, J.S. Liu, Z.S. Hu, and W. Qiao Studies on quality standard of Suanzaorenhehuan Formula Lishizhen Medicine and Materia Research 2 2011 364 365
27. M. Liotti, and H.S. Mayberg The role of functional neuroimaging in the neuropsychology of depression Journal of Clinical and Experimental Neuropsychology 23 2001 121 136
28. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randal Protein measurement with folin phenol reagent Journal of Biological Chemistry 193 1951 265 275
29. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Medicine 3 2006 e442
30. Y.S. Mineur, D.J. Prasol, C. Belzung, and W.E. Crusio Agonistic behavior and unpredictable chronic mild stress in mice Behavior Genetics 33 2003 513 519
31. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Lancet 349 1997 1498 1504
32. C.B. Nemeroff Recent findings in the pathophysiology of depression Focus 6 2008 3 14
33. E.J. Nestler, M. Barrot, R.J. Dileone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25
34. D.J. Nutt The role of dopamine and norepinephrine in depression and antidepressant treatment Journal of Clinical Psychiatry 67 2006 3 8
35. G.I. Papakostas Dopaminergic-based pharmacotherapies for depression European Neuropsychopharmacology 16 2006 391 402
36. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Archives Internationales de Pharmacodynamie et de Thérapie 229 1977 327 336
37. J.J. Schildkraut The catecholamine hypothesis of affective disorders: a review of supporting evidence American Journal of Psychiatry 122 1965 509 522
38. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl) 85 1985 367 370
39. A.F. Thachil, R. Mohan, and D. Bhugra The evidence base of complementary and alternative therapies in depression Journal of Affective Disorders 97 2007 23 35
40. A.S. Welch, and B.L. Welch Solvent extraction method for simultaneous determination of norepinephrine, dopamine, serotonin, and 5-hydroxyindoleacetic acid in a single mouse brain Analytical Biochemistry 30 1969 161 179
41. P. Willner Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation Psychopharmacology (Berl) 134 1997 319 329
42. M.L. Wong, and J. Licinio Research and treatment approaches to depression Nature Reviews Neuroscience 2 2001 343 351
43. X. Xia, G. Cheng, Y. Pan, Z.H. Xia, and L.D. Kong Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test Journal of Ethnopharmacology 110 2007 356 363
44. Z.F. Yu, L.D. Kong, and Y. Chen Antidepressant activity of aqueous extract of Curcuma longa in mice Journal of Ethnopharmacology 83 2002 161 165
45. Y. Zhang A mental-tranquilizer - Albizzia julibrssin Specialized Households 3 2003 19 20
46. L. Zheng, and G.Q. Liu Effect of Hyperium extracts on monoamine oxidase and monoamine neurotransmitters Journal of China Pharmaceutical University 33 2002 138 141
47. B.H. Zhou, X.J. Li, D. Yang, F.W. Huang, M. Liu, G.H. Wang, and X.M. Hu Effect of Apocynum venetum on the activity of MAO in mice China Pharmacist 9 2006 689 692
48. T.L. Zhu, Z.S. Hu, L. Li, and W. Qiao Study on the antidepressant effect of active fraction from Semen Zizyphi Spinosae Acta Academiae Medicine CPAF 18 2009 420 425